2004
DOI: 10.1091/mbc.e03-06-0379
|View full text |Cite
|
Sign up to set email alerts
|

ΔF508 CFTR Pool in the Endoplasmic Reticulum Is Increased by Calnexin Overexpression

Abstract: The most common cystic fibrosis transmembrane conductance regulator (CFTR) mutant in cystic fibrosis patients, ⌬F508 CFTR, is retained in the endoplasmic reticulum (ER) and is consequently degraded by the ubiquitin-proteasome pathway known as ER-associated degradation (ERAD). Because the prolonged interaction of ⌬F508 CFTR with calnexin, an ER chaperone, results in the ERAD of ⌬F508 CFTR, calnexin seems to lead it to the ERAD pathway. However, the role of calnexin in the ERAD is controversial. In this study, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
78
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 90 publications
(89 citation statements)
references
References 66 publications
(77 reference statements)
10
78
1
Order By: Relevance
“…This labeling pattern could be explained by the formation of an ␣ 1 -ATZ-calnexin complex that is not dissociated during the formation of inclusions, whereas KDEL-possessing soluble proteins are not associated with, or become dissociated from, ␣ 1 -ATZ before evolution into inclusions within the ER lumen or during movement out of the ER. These structures share some characteristics with the recently described ER quality control compartment or concentric membranous body, including membranous morphology and colocalization of ER membrane chaperone calnexin and mutant substrate proteins (38,39). Because proper function of the ER appears to be maintained while mutant proteins accumulate within these structures, they may constitute reservoirs of aberrant proteins similar to what has been attributed to aggresomes (40,41).…”
Section: Discussionmentioning
confidence: 69%
“…This labeling pattern could be explained by the formation of an ␣ 1 -ATZ-calnexin complex that is not dissociated during the formation of inclusions, whereas KDEL-possessing soluble proteins are not associated with, or become dissociated from, ␣ 1 -ATZ before evolution into inclusions within the ER lumen or during movement out of the ER. These structures share some characteristics with the recently described ER quality control compartment or concentric membranous body, including membranous morphology and colocalization of ER membrane chaperone calnexin and mutant substrate proteins (38,39). Because proper function of the ER appears to be maintained while mutant proteins accumulate within these structures, they may constitute reservoirs of aberrant proteins similar to what has been attributed to aggresomes (40,41).…”
Section: Discussionmentioning
confidence: 69%
“…OSER formation by these mutant proteins may in some way depend on their interaction with the ER chaperone calnexin [57][58][59]. However, the role of calnexin in OSER induction is unclear and deserves further investigation.…”
Section: Smooth Ermentioning
confidence: 99%
“…Regarding the implications for pathology, OSER has been observed to form in response to the expression of mutant, disease-causing proteins, like torsin A [56], ΔF-cystic fibrosis transmembrane conductance regulator (CFTR) [57] and mutant peripheral myelin protein-22 (PMP-22) [58], which are responsible for early onset generalized torsion dystonia, cystic fibrosis and inherited peripheral neuropathies (Dejerine Sottas syndrome and CharcotMarie-Tooth 1A), respectively. OSER formation by these mutant proteins may in some way depend on their interaction with the ER chaperone calnexin [57][58][59].…”
Section: Smooth Ermentioning
confidence: 99%
“…In addition, analysis of calnexin's role in degradation of misfolded CFTR and CFTR⌬F508 has provided mixed results. Overexpression of calnexin results in the accumulation of ⌬F508 CFTR in the ER (Okiyoneda et al, 2004), but RNA interference (RNAi)-mediated decrease of calnexin levels or deletion of the calnexin gene does not inhibit degradation of wild-type (WT) or ⌬F508 CFTR (Farinha and Amaral, 2005;Okiyoneda et al, 2008).…”
Section: Introductionmentioning
confidence: 99%